Veru Return on Tangible Equity 2010-2023 | VERU
Current and historical return on tangible equity values for Veru (VERU) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Veru Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2023-12-31 | $-0.06B | $0.05B | -303.61% |
| 2023-09-30 | $-0.09B | $0.01B | -494.74% |
| 2023-06-30 | $-0.13B | $0.02B | -373.33% |
| 2023-03-31 | $-0.14B | $0.01B | -249.56% |
| 2022-12-31 | $-0.12B | $0.04B | -136.07% |
| 2022-09-30 | $-0.08B | $0.07B | -75.45% |
| 2022-06-30 | $-0.05B | $0.11B | -36.15% |
| 2022-03-31 | $-0.03B | $0.13B | -19.74% |
| 2021-12-31 | $-0.02B | $0.14B | -11.29% |
| 2021-09-30 | $0.01B | $0.14B | 5.98% |
| 2021-06-30 | $-0.00B | $0.14B | -1.16% |
| 2021-03-31 | $-0.00B | $0.15B | -1.87% |
| 2020-12-31 | $0.00B | $0.04B | 5.48% |
| 2020-09-30 | $-0.02B | $0.02B | -200.00% |
| 2020-06-30 | $-0.01B | $0.01B | -153.85% |
| 2020-03-31 | $-0.01B | $0.00B | -200.00% |
| 2019-12-31 | $-0.01B | $0.00B | -236.36% |
| 2019-09-30 | $-0.01B | $0.01B | -165.52% |
| 2019-06-30 | $-0.02B | $0.01B | -261.54% |
| 2019-03-31 | $-0.02B | $0.01B | -338.46% |
| 2018-12-31 | $-0.02B | $0.01B | -258.82% |
| 2018-09-30 | $-0.02B | $0.00B | -234.15% |
| 2018-06-30 | $-0.02B | $0.01B | -140.00% |
| 2018-03-31 | $-0.01B | $0.01B | -74.67% |
| 2017-12-31 | $-0.01B | $0.02B | -56.47% |
| 2017-09-30 | $-0.01B | $0.02B | -38.71% |
| 2017-06-30 | $-0.01B | $0.02B | -22.64% |
| 2017-03-31 | $-0.00B | $0.02B | -13.45% |
| 2016-12-31 | $-0.00B | $0.03B | -6.15% |
| 2016-09-30 | $0.00B | $0.03B | 0.00% |
| 2016-06-30 | $0.00B | $0.04B | 8.63% |
| 2016-03-31 | $0.00B | $0.04B | 8.89% |
| 2015-12-31 | $0.01B | $0.04B | 15.27% |
| 2015-09-30 | $0.01B | $0.03B | 16.00% |
| 2015-06-30 | $0.00B | $0.03B | 10.00% |
| 2015-03-31 | $0.00B | $0.03B | 10.26% |
| 2014-12-31 | $0.00B | $0.03B | 3.51% |
| 2014-09-30 | $0.00B | $0.03B | 3.51% |
| 2014-06-30 | $0.01B | $0.03B | 30.77% |
| 2014-03-31 | $0.01B | $0.03B | 31.30% |
| 2013-12-31 | $0.01B | $0.03B | 42.48% |
| 2013-09-30 | $0.02B | $0.03B | 55.56% |
| 2013-06-30 | $0.02B | $0.03B | 63.37% |
| 2013-03-31 | $0.02B | $0.03B | 76.60% |
| 2012-12-31 | $0.02B | $0.02B | 80.00% |
| 2012-09-30 | $0.02B | $0.02B | 82.05% |
| 2012-06-30 | $0.01B | $0.02B | 73.24% |
| 2012-03-31 | $0.01B | $0.02B | 62.50% |
| 2011-12-31 | $0.01B | $0.02B | 52.46% |
| 2011-09-30 | $0.01B | $0.02B | 33.90% |
| 2011-06-30 | $0.01B | $0.01B | 41.38% |
| 2011-03-31 | $0.01B | $0.01B | 42.11% |
| 2010-12-31 | $0.01B | $0.02B | 58.18% |
| 2010-09-30 | $0.01B | $0.02B | 53.85% |
| 2010-06-30 | $0.00B | $0.01B | 24.49% |
| 2010-03-31 | $0.00B | $0.01B | 33.33% |
| 2009-12-31 | $0.00B | $0.01B | 34.78% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.193B | $0.016B |
| Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.474B | 24.35 |
| Stryker (SYK) | United States | $128.161B | 31.78 |
| Boston Scientific (BSX) | United States | $106.966B | 34.07 |
| Medtronic (MDT) | Ireland | $106.730B | 15.11 |
| EssilorLuxottica (ESLOY) | France | $99.574B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.648B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.127B | 29.82 |
| ResMed (RMD) | United States | $27.032B | 27.03 |
| Terumo (TRUMY) | Japan | $25.476B | 35.98 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.896B | 16.03 |
| Baxter (BAX) | United States | $20.785B | 15.16 |
| Koninklijke Philips (PHG) | Netherlands | $19.474B | 15.53 |
| Insulet (PODD) | United States | $11.711B | 61.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.741B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.934B | 23.64 |
| BellRing Brands (BRBR) | United States | $7.285B | 39.17 |
| Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
| Haemonetics (HAE) | United States | $4.379B | 22.40 |
| Perrigo (PRGO) | Ireland | $4.232B | 12.10 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Envista Holdings (NVST) | United States | $3.485B | 13.26 |
| Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.46 |
| QuidelOrtho (QDEL) | United States | $2.730B | 9.91 |
| Neogen (NEOG) | United States | $2.679B | 25.77 |
| Green Thumb Industries (GTBIF) | United States | $2.630B | 83.33 |
| ICU Medical (ICUI) | United States | $2.357B | 17.58 |
| TG Therapeutics (TGTX) | United States | $2.161B | 699.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.928B | 0.00 |
| Owens & Minor (OMI) | United States | $1.895B | 18.19 |
| Verano Holdings (VRNOF) | United States | $1.790B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
| InMode (INMD) | Israel | $1.458B | 7.55 |
| LeMaitre Vascular (LMAT) | United States | $1.437B | 47.43 |
| National Vision Holdings (EYE) | United States | $1.388B | 43.24 |
| AdaptHealth (AHCO) | United States | $1.300B | 9.78 |
| Warby Parker (WRBY) | United States | $1.287B | 0.00 |
| AtriCure (ATRC) | United States | $1.115B | 0.00 |
| MacroGenics (MGNX) | United States | $0.982B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.899B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.779B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.712B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.693B | 14.98 |
| Evolus (EOLS) | United States | $0.666B | 0.00 |
| Quanterix (QTRX) | United States | $0.613B | 0.00 |
| Jin Medical (ZJYL) | China | $0.547B | 0.00 |
| Valneva SE (VALN) | France | $0.540B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.509B | 11.02 |
| PetIQ (PETQ) | United States | $0.487B | 18.17 |
| TerrAscend (TSNDF) | Canada | $0.478B | 0.00 |
| ZimVie (ZIMV) | United States | $0.430B | 26.35 |
| OraSure Technologies (OSUR) | United States | $0.421B | 6.96 |
| Biote (BTMD) | United States | $0.417B | 3.96 |
| Aurora Cannabis (ACB) | Canada | $0.393B | 0.00 |
| Surmodics (SRDX) | United States | $0.371B | 40.11 |
| Zynex (ZYXI) | United States | $0.361B | 41.59 |
| Viemed Healthcare (VMD) | United States | $0.314B | 31.11 |
| Cerus (CERS) | United States | $0.301B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.241B | 14.70 |
| Organigram Holdings (OGI) | Canada | $0.199B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.192B | 0.00 |
| Omeros (OMER) | United States | $0.176B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.163B | 0.00 |
| High Tide (HITI) | Canada | $0.160B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.159B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.134B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.130B | 65.20 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
| InterCure (INCR) | Israel | $0.122B | 20.54 |
| Fonar (FONR) | United States | $0.102B | 8.80 |
| Cellectar Biosciences (CLRB) | United States | $0.099B | 0.00 |
| MariMed (MRMD) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.088B | 0.00 |
| Brainsway (BWAY) | Israel | $0.084B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Chimerix (CMRX) | United States | $0.081B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.060B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 15.04 |
| Bright Green (BGXX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.54 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |